CHEMICAL OR BIOLOGICAL AGENTS

Brand Owner (click to sort) Address Description
CHONDRONEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated cartilage tissue in vitro or in vivo;
CONNEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to proliferate in vitro or in vivo;
DERMANEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated dermis tissue in vitro or in vivo;
MYONEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated muscle tissue in vitro or in vivo;
OSTEODX OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for diagnosing the status of bone forming cells;
OSTEONEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated bone tissue in vitro or in vivo;
PROMESYN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to proliferate in vitro or in vivo;
PROSTERNIX OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to proliferate in vitro or in vivo;
STROMANEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated stroma tissue in vitro or in vivo;
TENDANEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated tendon tissue in vitro or in vivo;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus for neutralizing biological and/or chemical warfare agents using an ozone-containing solution. The ozone-containing solution is produced by combining ozone-containing gas with an ozone vehicle, such as an organic solution. The ozone-vehicle prolongs the shelf life of the ozone to allow for extended periods of storage. A storage container is used to store the ozone-containing solution and facilitate its transportation to an environment contaminated by the biological and/or chemical warfare agents, or near a potential site for biological or chemical attack. The ozone-containing solution is drawn out of the storage container to apply it to a contaminated environment.